Cortechs.ai

Join us at #RSNA2024 on Tuesday, December 3rd at 9:00 AM CET in the North Hall - Level 3 of McCormick Place for an unmissable session by Dr. Suzie Bash: "Transforming Radiology with Cutting-Edge AI-powered Quantitative MRI." 🔍 Discover how AI-powered QMRI (Quantitative MRI) is revolutionizing diagnostic accuracy and efficiency in radiology! Dr. Bash will showcase real-world case studies and dive into how QMRI reduces reader subjectivity, providing more reliable and reproducible imaging results. Join us to learn how this advanced technology is leading to improved patient outcomes and transforming clinical workflows! 👉 Sign up now: https://lnkd.in/gBz-mejB *Registration required* #RSNA #AIinHealthcare #QuantitativeMRI #ImagingInnovation #Radiology #QMRI 

📢 It's International Brain Tumor Awareness Week! At Cortechs.ai, we're committed to advancing the assessment and treatment of brain tumors. 🧠💪 Our FDA-cleared software, NeuroQuant® Brain Tumor, harnesses the power of AI and advanced diffusion MRI to assist radiologists, oncologists, and Tumor Boards in providing precise, objective analyses of brain tumors over time. With 3D volumetric quantification and visualization, NeuroQuant® Brain Tumor delivers greater accuracy in monitoring tumor progression and treatment response. Let's keep pushing for better outcomes and hope for all those affected by brain tumors.🩶 Learn more about NeuroQuant® Brain Tumor now: https://lnkd.in/gbY3pcza #BrainTumorAwareness #AIInHealthcare #NeuroQuant #BrainHealth #MedicalInnovation #AI

We had a great time attending WNRS in Hawaii and connecting with so many amazing neuroradiology professionals! 🌺🧠 Thank you to everyone who stopped by our booth—it was a pleasure sharing how Cortechs.ai’s precise #AI tools can transform your radiological workflow. We’re excited to continue the conversation at RSNA next month! Stop by Booth 6551 to see how our advanced solutions offer unique insights to enhance disease prediction and monitoring.   See you there! 👋 #Neuroimaging #WNRS2024 #Neuroradiology #RSNA2024

🌟 New blog alert! The newest update of the 2024 Alzheimer’s Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for ARIA Monitoring guidelines brings new information for radiologists monitoring ARIA in Alzheimer’s patients. 📈 FDA-approved therapies such as lecanemab and donanemab are now covered by CMS, which shifts the focus to practical implementation, such as standard imaging protocols and the integration of AI tools. For example, NeuroQuant ARIA can help automate detection, reducing variability and improving patient outcomes. ✨🧠 🔗 Read more about the latest guidelines and how AI is shaping the future of ARIA monitoring here: https://lnkd.in/gA-c337m

🚨 Mark your calendars! 🚨 Join us at #RSNA2024 on Monday, Dec 2 at 9 AM for an insightful session by Dr. Eric Weinberg: "Clinical Utility of RSI for Multi-Parametric Prostate MRI." 🔬 Dive into real case studies where RSI (restriction spectrum imaging) moved patients from PI-RADS 3 to more definitive diagnoses. Dr. Weinberg will showcase cases highlighting the clinical impact of RSI in prostate MRI and provide a high-level overview of the cutting-edge technology and physics behind this powerful tool. Don’t miss out on this opportunity to see how RSI is shaping the future of prostate imaging! Sign up now: https://lnkd.in/giweX9UT *Registration required* #RSNA #ProstateMRI #RSI #AIinHealthcare #ImagingInnovation #Radiology

Curious about NeuroQuant MVID? Watch our latest demo to see how this powerful tool simplifies brain volume and microhemorrhage identification.🔍 It's designed to give clinicians faster, more reliable insights. Click the link below to see it in action! 🎥 🔗: https://bit.ly/mvid-demo

Cortechs.ai is excited to attend #RSNA2024 in Chicago from December 1-4! 🎉 Visit us at Booth 6551 in the North Hall at McCormick Place to discover how our #AI solutions are enhancing patient care by empowering physicians and clinicians to detect, diagnose, and treat diseases more effectively. We hope to see you there! Learn more: https://bit.ly/rsna2024 #Radiology #Healthcare #Neuroimaging #AI

Welcome to Cortechs.ai, Julie Ott! 🎉 With 25 years of sales experience in healthcare, Julie Ott has developed expertise across pharmaceuticals, medical devices, and software. For the past 11 years, her focus has been on the neurovascular space, where she has successfully sold life-saving devices and AI-powered software designed to detect large vessel strokes, cerebral aneurysms, and cerebral bleeds. 🧠 Now, as part of the Cortechs team, Julie is excited to continue making an impact: "I'm thrilled to introduce innovative software that delivers critical data for rapid, informed decision-making. The company's customer-centric culture aligns perfectly with my passion for partnering with physicians, hospitals, and imaging centers to provide gold standard treatment to patients." 🌟Julie is eager to broaden her horizons into neurology, diving into areas like brain tumors, neurodegenerative diseases, and neuroimmunological disorders. We're excited to have her on board as she continues building relationships with neurologists, neuroradiologists, and neurosurgeons while forging new ones in the field. Welcome to the Cortechs family!

💡 Wondering how automated segmentation and volumetric analysis can transform your workflow? Excited about the FDA-cleared NeuroQuant ARIA?  🌺 Join us next week at the WNRS 2024 conference, hosted at the stunning Westin Hapuna in Waimea, Hawaii! Visit us at Booth #7 to discuss how our advanced quantitative volumetric solutions provide unique insights and assist in clinical assessments. We hope to see you there! #WNRS2024 #AI #Radiology #Neuroimaging #Neuroquant

October is ADHD Awareness Month! 🧡 This month, we’re highlighting Attention-Deficit/Hyperactivity Disorder (ADHD) and its impact on individuals and families to raise awareness and support those affected. 📊 ADHD affects millions globally. At Cortechs.ai, our NeuroQuant® Custom Volumetric report uses advanced MR imaging to assess brain structure volumes, helping clinicians evaluate ADHD symptoms. 🧠 Our reports, for patients aged 3 to 100, provide volume measurements for up to nine brain structures and track changes over time, enhancing ADHD management. Research links reductions in brain volume to attention control and hyperactivity. Our NeuroQuant® solution empowers early evaluation and ongoing assessment in patients as young as 4. Learn more about how our NeuroQuant® solutions are helping to improve early detection and accurate assessments of ADHD: https://bit.ly/3zUOVvd #ADHD #ADHDAwarenessMonth #NeuroQuant #AI #HealthcareInnovation